CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 8,000 shares of BMRN on 11/16/2012 at an average price of $48.05 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $5.92 billion; its shares were traded at around $47.89 with and P/S ratio of 13.4.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.

CEO Recent Trades:

• CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 11/16/2012 at the average price of 48.05. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 0.33% since.
• CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 11/14/2012 at the average price of 48.5. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 1.26% since.
• CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 11/09/2012 at the average price of 47.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 0.57% since.
• CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 10/31/2012 at the average price of 37.96. Jean Jacques Bienaime owns at least 174,691 shares after this. The price of the stock has increased by 26.16% since.
• CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 10/22/2012 at the average price of 41.86. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 14.41% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.

Directors and Officers Recent Trades:

• EVP, Technical Operations Robert Baffi sold 20,000 shares of BMRN stock on 11/15/2012 at the average price of 51. Robert Baffi owns at least 100,413 shares after this. The price of the stock has decreased by 6.1% since.
• VP, Corporate Controller Brian Mueller sold 15,812 shares of BMRN stock on 11/15/2012 at the average price of 50. Brian Mueller owns at least 15,340 shares after this. The price of the stock has decreased by 4.22% since.
• SVP, General Counsel George Eric Davis sold 99,075 shares of BMRN stock on 11/12/2012 at the average price of 48.45. George Eric Davis owns at least 51,322 shares after this. The price of the stock has decreased by 1.16% since.
• SVP, Chief Commercial Of Jeffrey Robert Ajer sold 265 shares of BMRN stock on 11/12/2012 at the average price of 48.11. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has decreased by 0.46% since.
• Director Elaine J Heron sold 1,875 shares of BMRN stock on 11/12/2012 at the average price of 48.33. Elaine J Heron owns at least 14,025 shares after this. The price of the stock has decreased by 0.91% since.

For the complete insider trading history of BMRN, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool